To Test the treatment effect of Ayurvedic medicine Vidangadi Loha Dwitiya with and without Vaman karma (Therapeutic emesis) in Anemia patient

An open label comparative prospective clinical study to evaluate the efficacy of Vidangadi Loha Dwitiya with and without Vaman karma in the management of Pandu with special reference to Anemia - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/02/103132

Enrollment

Registered

2026-02-05

Start date

Unknown

Completion date

Unknown

Last updated

2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D539- Nutritional anemia, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Participants of any gender aged 18 60 years and diagnosed with anemia 2.Hemoglobin level between 8 10.9gm/dl 3.Willing to provide written informed consent

Exclusion criteria

Exclusion criteria: 1.Patients with congenital hematological disorders (e.g. SCA, Hemophilia), Leukemia. 2.Patients with uncontrolled bronchial asthma, cardiovascular disease, cerebrovascular disease. 3.Patients with tuberculosis, HIV, or malignancy. 4.Pregnant or lactating women. 5.Known cases of renal dysfunction.

Design outcomes

Primary

Measure	Time frame
1.Improvement in Hemoglobin Levels. 2.Improvement in classical signs and symptoms of Pandu. 3.Improvement in Quality of life through Fatigue Scale.Timepoint: 1.0th Day and 90th Day 2.0th Day, 30th Day, 60th Day, 90th Day. 3.0th Day, 30th Day, 60th Day, 90th Day.	—

Secondary

Measure	Time frame
1.Comparison between Group A (Vidangadi Loha Dwitiya with Vaman Karma) and Group B (Vidangadi Loha Dwitiya without Vaman Karma) in terms of symptom relief. 2.Comparison between Group A (Vidangadi Loha Dwitiya with Vaman Karma) and Group B (Vidangadi Loha Dwitiya without Vaman Karma) in terms of laboratory parameters. 3.Monitoring for adverse events related to the medication. 4.Monitoring for complications related to the Vaman Karma procedure. Timepoint: 1.0th Day, 30th Day, 60th Day, 90th Day. 2.0th Day 90th Day 3.0th Day, 30th Day, 60th Day, 90th Day. 4.throughout the procedure period.	—

Measure

Time frame

1.Comparison between Group A (Vidangadi Loha Dwitiya with Vaman Karma) and Group B (Vidangadi Loha Dwitiya without Vaman Karma) in terms of symptom relief. 2.Comparison between Group A (Vidangadi Loha Dwitiya with Vaman Karma) and Group B (Vidangadi Loha Dwitiya without Vaman Karma) in terms of laboratory parameters. 3.Monitoring for adverse events related to the medication. 4.Monitoring for complications related to the Vaman Karma procedure. Timepoint: 1.0th Day, 30th Day, 60th Day, 90th Day. 2.0th Day 90th Day 3.0th Day, 30th Day, 60th Day, 90th Day. 4.throughout the procedure period.

—

Countries

India

Contacts

Public ContactDr Jyotiben H Parmar

Parul institute of Ayurved And Research Parul University

dr.vaishalid@gmail.com9096082950

Outcome results